Catalyst Wire Dossier Catalyst Wire Dossier

Anotinib hydrochloride

Anotinib hydrochloride · Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anotinib hydrochloride, covering 2022-02-18 to 2022-02-18. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma [Phase 3]

See pricing